Are there specific safety risks with compounded injectable GLP-1 medications compared to brand-name options
32 Included patients were matched for age, sex, race and ethnicity, cardiovascular diseases, DR severity (including PDR and DME status), history of tobacco use, body mass index, and hemoglobin A1c percentage
Recommended strategies to preserve lean mass during GLP-1 therapy include protein intake greater than 1.2 g/kg/day, evenly distributed across meals, combined with aerobic activity and structured resistance training
Thousands of anecdotal reports support its safety for: Subcutaneous and intramuscular injection Oral use for GI issues Short-term protocols (26 weeks) Still, because of its unregulated status, quality and dosing inconsistencies in peptide sourcing pose additional risks
Three or more symptoms-restlessness or feeling tense, being quickly tired, trouble paying attention, anger, muscle tightness and disturbed sleep can be linked to anxiety
Over the last few years, a number of dietary supplements have been developed to help restore cellular glutathione to adequate levels and thus optimise the bodys defenses